Virus therapy offered to fight tough melanoma cases
NCT ID NCT06590480
Summary
This program provided early access to an experimental treatment combining a modified virus (VO) with an existing immunotherapy drug (nivolumab) for adults with advanced skin cancer (melanoma) that had worsened despite standard treatment. The goal was to see if the virus could help the immune system better attack the cancer. The program is no longer accepting new patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.